Chest
Volume 96, Issue 1, July 1989, Pages 178-180
Journal home page for Chest

Consensus Conference on Artificial Airways in Patients Receiving Mechanical Ventilation

https://doi.org/10.1378/chest.96.1.178Get rights and content

Section snippets

Benefits

Tracheotomy has several benefits in the patient receiving mechanical respiratory support. The

Implications for Reimbursement for Patients Receiving Mechanical Ventilation

An appropriate reimbursement system for patients on mechanical respiratory support should be based on goals that it: (1) encourage appropriate quality of patient care; (2) encompass all patients; and (3) avoid over/underutilization of health care resources.

REFERENCES (4)

There are more references available in the full text version of this article.

Cited by (308)

  • Association between tracheostomy and survival in patients with coronavirus disease 2019 who require prolonged mechanical ventilation for more than 14 days: A multicenter cohort study

    2023, Auris Nasus Larynx
    Citation Excerpt :

    Consequently, the potential improvement of outcomes caused by implementation of tracheostomy in COVID-19 patients has been investigated and described in several case series since the outbreak of the pandemic [16,17,28,29]. Conventional international consensus recommends MV via translaryngeal endotracheal intubation for patients with an expected MV duration <10 days and transition to tracheostomy for those with an expected MV duration of >21 days [30]. As numerous reports have shown that early tracheostomy is associated with improved patient outcomes [6,31], tracheostomy is widely considered to be performed within 1–2 weeks after MV initiation in critical care settings [32–34].

View all citing articles on Scopus
View full text